
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
GATA-6 CRISPR/Cas9 KO Plasmid (h) | sc-400724 | 20 µg | $397.00 |
GATA6 encodes GATA-6, a zinc-finger transcription factor that binds GATA motifs to regulate lineage specification and differentiation programs in endoderm- and mesoderm-derived tissues. It participates in transcriptional networks with factors such as NKX2-5 and TBX family members to coordinate organogenesis and cell fate decisions, and it interfaces with signaling inputs including WNT, BMP, and TGF-β pathways. In adult cells, GATA-6 contributes to epithelial and smooth muscle gene regulation, cellular metabolism, and stress-responsive transcriptional remodeling. Dysregulated GATA6 activity has been associated with developmental defects and is frequently studied in the context of altered differentiation states and transcriptional dependencies observed across multiple disease models, including cancer.
GATA-6 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the GATA6 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the GATA6 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the GATA6 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish GATA-6 protein expression.
This CRISPR knockout system enables efficient generation of GATA6-deficient cell models for investigation of GATA-6 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.